SCOR (SCR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
15 Sep, 2026Opening remarks and agenda
The meeting was opened by the chair, welcoming shareholders, board members, and committee chairs, and confirming the presence of candidates for new board directors.
The bureau was constituted, with tellers and the secretary appointed, and the meeting was declared properly constituted with a quorum of 70.99% of voting rights represented.
The agenda included presentations from the CEO, committee chairs, statutory auditors, and a Q&A session with shareholders.
Financial performance review
Net income reached a record EUR 855 million in 2025, the highest ever, with all activities contributing.
Solvency ratio increased to 215%, above the target range, and economic value rose by 13.7%.
Equity yield was 19.1%, surpassing the Forward 2026 objective of 12%.
P&C combined ratio was below 87%, and Life technical result exceeded EUR 450 million.
Dividend proposed at EUR 1.82, up 5.6% from previous years, with a new floor set at EUR 1.90.
Board and executive committee updates
Two new independent directors were proposed, with succession planning underway for outgoing members.
The Executive Committee was recently renewed, emphasizing technical and human caliber.
CEO Thierry Léger’s mandate was renewed for three years, with a proposed 10% compensation increase.
Latest events from SCOR
- Resilient 2024 results, robust governance, and Forward 2026 strategy drive strong approvals.SCR
AGM 2025 - H1 2026 net income EUR 409m, ROE 19%, solvency 220%, P&C combined ratio 79.5%.SCR
Q2 2026 - Q1 2026 net income was EUR 225m, ROE 21.1%–21.7%, and solvency ratio rose to 220%.SCR
Q1 2026 - FY net income up to EUR 851M, ROE above 19%, dividend EUR 1.9/share, solvency 215%.SCR
Q4 2025 - Q2 net income EUR 226m, H1 EUR 425m, ROE 22.6%, solvency 210%, strong P&C and L&H.SCR
Q2 2025 - Forward 2026 targets 9% value growth, >12% ROE, higher-margin L&H, and robust reserves.SCR
Investor Day 2024 - Strong P&C and investments offset by L&H review one-offs; solvency robust at 203%.SCR
Q3 2024 - Q2 2024 net loss driven by L&H review, but P&C and solvency remain strong.SCR
Q2 2024 - Q1 2025 net income was EUR 200m, with 18.3% ROE and strong P&C and investment results.SCR
Q1 2025